The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay
Open accessAbstract
OBJECTIVE: To examine associations between prenatal use of selective serotonin reuptake inhibitors (SSRIs) and the odds of autism spectrum disorders (ASDs) and other developmental delays (DDs). METHODS: A total of 966 mother-child pairs were evaluated (492 ASD, 154 DD, 320 typical development [TD]) from the Childhood Autism Risks from Genetics and the Environment (CHARGE) Study, a population-based case-control study. Standardized measures confirmed developmental status. Interviews with biological mothers ascertained prenatal SSRI use, maternal mental health history, and sociodemographic information. RESULTS: Overall, prevalence of prenatal SSRI exposure was lowest in TD children (3.4%) but did not differ significantly from ASD (5.9%) or DD (5.2%) children. Among boys, prenatal SSRI exposure was nearly 3 times as likely in children with ASD relative to TD (adjusted odds ratio [OR]: 2.91; 95% confidence interval [CI]: 1.07–7.93); the strongest association occurred with first-trimester exposure (OR: 3.22; 95% CI: 1.17–8.84). Exposure was also elevated among boys with DD (OR: 3.39; 95% CI: 0.98–11.75) and was strongest in the third trimester (OR: 4.98; 95% CI: 1.20–20.62). Findings were similar among mothers with an anxiety or mood disorder history. CONCLUSIONS: In boys, prenatal exposure to SSRIs may increase susceptibility to ASD or DD. Findings from published studies on SSRIs and ASD continues to be inconsistent. Potential recall bias and residual confounding by indication are concerns. Larger samples are needed to replicate DD results. Because maternal depression itself carries risks for the fetus, the benefits of prenatal SSRI use should be carefully weighed against potential harms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies have observed associations between prenatal SSRI exposure and specific types of DD, including motor (32, 59) and speech/language delays (57).”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [32]
In the citing paper
“Relationships between DD and prenatal SSRIs were overall similar to those observed with ASD, and in agreement with previous null reports of prenatal SSRI use and ADHD (21, 25, 42), DD (32, 57), and ID (27, 58).”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [32]
In the citing paper
“However, reflecting the mixed evidence of this research area, our findings also contradict several other large studies conducted in Sweden,(30, 43) the Netherlands (44), California (31, 32), Canada (29), and Denmark (27, 28).”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [32]
In the citing paper
“These positive findings in other studies persisted even after efforts to reduce confounding by indication through adjustment for maternal psychiatric condition (29, 31, 43, 44), restriction to mothers with psychiatric conditions (27–30, 32), and propensity weighting methods (30).”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [32]
In the citing paper
“For ASD as the outcome, seven case–control studies (involving 291,468 patients and 13,243 cases of ASD) [17, 18, 26–29, 32] and eight cohort studies (involving 3,294,218 patients and 27,342 cases of ASD) [16, 19, 25, 30, 31, 33–35] were included.”
In the citing paper
“there was a total of 15 observational studies measuring ASD as an outcome [16–19, 25–35].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Measurement of Observer Agreement for Categorical Data
Landis, J. R., & Koch, G. G. (1977) · Biometrics · doi:10.2307/2529310 · Cited by 81,148
Mullen Scales of Early Learning
Bradley‐Johnson, S. (1997) · Psychology in the Schools · doi:10.1002/(sici)1520-6807(199710)34:4 · Cited by 2,329
Social Communication Questionnaire
Lund, E. M. (2014) · Encyclopedia of Special Education · doi:10.1002/9781118660584.ese2224 · Cited by 975
Autism Diagnostic Observation Schedule
Kim, S. H., & Lord, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-56782-2_1520-2 · Cited by 782
A transient placental source of serotonin for the fetal forebrain
Bonnin, A., Goeden, N., Chen, K., Wilson, M. L., King, J., Shih, J. C., Blakely, R. D., Deneris, E. S., & Levitt, P. (2011) · Nature · doi:10.1038/nature09972 · Cited by 608
Combining Information From Multiple Sources in the Diagnosis of Autism Spectrum Disorders
RISI, S., LORD, C., GOTHAM, K., CORSELLO, C., CHRYSLER, C., SZATMARI, P., COOK, E. H., LEVENTHAL, B. L., & PICKLES, A. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000227880.42780.0e · Cited by 581
Perinatal Risks of Untreated Depression during Pregnancy
Bonari, L., Pinto, N., Ahn, E., Einarson, A., Steiner, M. S., & Koren, G. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404901103 · Cited by 534
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Croen, L. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.73 · Cited by 510
Research works printed but not linked: 2
- Sparrow, 1984, Vineland Adaptive Behavior Scales Interview Edition Expanded Form
- Rothman, 2008, Validity in epidemiologic studies, 128
Cited by
Sorted by citations
Items 101–173 of 173
Brennan, P. A., Dunlop, A. L., Croen, L., Avalos, L. A., Salisbury, A. L., Hipwell, A. E., Nozadi, S. S., Sathyanarayana, S., Crum, R. M., Musci, R. J., et al. (2022) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-022-01000-5 · Cited by 20
Self-citationOrnoy, A., & Koren, G. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1430139 · Cited by 15
Is the Exposome Involved in Brain Disorders through the Serotoninergic System?
Sarrouilhe, D., Defamie, N., & Mesnil, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101351 · Cited by 17
Singal, D., Brownell, M. D., Chateau, D. G., Ruth, C., & Katz, L. Y. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013293 · Cited by 14
Kott, J., & Brummelte, S. (2019) · Hormones and Behavior · doi:10.1016/j.yhbeh.2019.01.004 · Cited by 15
Third-party prosocial behavior in adult female rats is impaired after perinatal fluoxetine exposure
Heinla, I., Heijkoop, R., Houwing, D. J., Olivier, J. D. A., & Snoeren, E. M. S. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112899 · Cited by 17
Srividhya, D., Korlimarla, A., Ravikumar, G., Snijesh, V. P., Kaku, S. M., & Visweswariah, A. M. (2022) · Birth Defects Research · doi:10.1002/bdr2.2119 · Cited by 15
Ackerman, S., Schoenbrun, S., Hudac, C., & Bernier, R. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3246-6 · Cited by 12
Pregnant women, prescription, and fetal risk
Éléfant, É., Hanin, C., & Cohen, D. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64150-2.00027-7 · Cited by 12
Meconium exposure and autism risk
Miller, K. M., Xing, G., & Walker, C. K. (2016) · Journal of Perinatology · doi:10.1038/jp.2016.200 · Cited by 11
Boukhris, T., & Bérard, A. (2015) · Journal of Pediatric Genetics · doi:10.1055/s-0035-1556744 · Cited by 13
Ramsteijn, A. S., Verkaik‐Schakel, R. N., Houwing, D. J., Plösch, T., & Olivier, J. D. A. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01270-z · Cited by 10
The Evolving Landscape of Functional Models of Autism Spectrum Disorder
Ranjan, J., & Bhattacharya, A. (2025) · Cells · doi:10.3390/cells14120908 · Cited by 10
Belovičová, K., Šimončičová, E., Viñas-Noguera, M., Dubovický, M., & Bögi, E. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112944 · Cited by 10
Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?
Pedersen, L. H. (2015) · Pediatric Drugs · doi:10.1007/s40272-015-0141-5 · Cited by 11
Perinatal MAO Inhibition Produces Long-Lasting Impairment of Serotonin Function in Offspring
Burke, M., Fillion, M., Mejia, J. M., Ervin, F. R., & Palmour, R. M. (2018) · Brain Sciences · doi:10.3390/brainsci8060106 · Cited by 10
Kapra, O., Rotem, R. S., & Gross, R. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.555740 · Cited by 10
Molina‐Jiménez, T., Limón‐Morales, O., & Bonilla‐Jaime, H. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.01.004 · Cited by 8
Smearman, E., Hendrix, C. L., Winiarski, D. A., Johnson, K. C., Smith, A. K., Ousley, O., Stowe, Z. N., Newport, D. J., & Brennan, P. A. (2019) · Development and Psychopathology · doi:10.1017/s0954579418001372 · Cited by 9
Leussis, M. P., Thanos, J. M., Powers, A. E., Peterson, E., Head, J. P., McGovern, N. J., Malarkey, F. J., & Drake, A. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173293 · Cited by 9
Ackerman, S., Schoenbrun, S., Hudac, C. M., & Bernier, R. (2017) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-017-3301-3 · Cited by 8
Heuvelman, H., Davies, N. M., Ben‐Shlomo, Y., Emond, A. M., Evans, J., Gunnell, D., Liebling, R. E., Morris, R. W., Payne, R., Storey, C., et al. (2023) · Health Technology Assessment · doi:10.3310/aqtf4490 · Cited by 11
Are the SSRI antidepressants safe in pregnancy? Understanding the debate
Urato, A. C. (2015) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-150646 · Cited by 7
Do Parental Comorbidities Affect the Severity of Autism Spectrum Disorder?
Aldera, H., Hilabi, A. S., Elzahrani, M. R., Alhamadh, M. S., Alqirnas, M. Q., Alkahtani, R. M., & Masuadi, E. (2022) · Cureus · doi:10.7759/cureus.32702 · Cited by 7
Higher autism in children of women with psychiatric diagnoses
Wieckowski, B. M., Mukhtar, Y., Lee, J. J., Xing, G., & Walker, C. K. (2016) · Research in Autism · doi:10.1016/j.rasd.2016.10.004 · Cited by 6
Sterol pathway disruption in pregnancy: a link to autism
Peeples, E. S., Anzalone, A. J., Dai, R., Reisher, E., Korade, Ž., & Mirnics, K. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03610-7 · Cited by 5
Effect of Maternal ±Citalopram Exposure on P11 Expression and Neurogenesis in the Mouse Fetal Brain
King, J. R., Velasquez, J. C., Torii, M., & Bonnin, A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00339 · Cited by 6
Santos, J. X., Rasga, C., & Vicente, A. M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95758 · Cited by 6
Developmental Fluoxetine Exposure Alters Behavior and Neuropeptide Receptors in the Prairie Vole
Lawrence, R. H., Palumbo, M., Freeman, S. M., Guoynes, C. D., & Bales, K. L. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.584731 · Cited by 6
Kępińska, A. P., Robakis, T. K., Smout, S., Bercovitch, R., Cohen, L., Mahjani, I. C. G., Skalkidou, A., Bergink, V., & Mahjani, B. (2026) · Psychological Medicine · doi:10.1017/s0033291725103139 · Cited by 11
Chan, J. K. N., Zhong, A. H. F., Lam, J. Y. H., Wong, C. S. M., Solmi, M., Correll, C. U., & Chang, W. C. (2026) · The Lancet Psychiatry · doi:10.1016/s2215-0366(26)00089-1 · Cited by 6
Béroule, D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.585395 · Cited by 4
Stohl, H. E., Kohm, A. D., & Dossett, E. C. (2016) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-16915057 · Cited by 5
Velasquez, J. C., & Bonnin, A. (2015) · Neuromethods · doi:10.1007/978-1-4939-3014-2_12 · Cited by 4
Epidemiology of the Use of Psychotropic Drugs in Pregnant and Nursing Women
Alwan, S. S., & Bérard, A. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_1 · Cited by 3
Roles of serotonin in the fetal brain
Zhao, Q., & Bonnin, A. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00024-4 · Cited by 3
Bezenah, J. C., Tejada, A. N., Garcia, D. A., Lopez, K., Richie, J. A., Amodeo, D. A., & Amodeo, L. R. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173534 · Cited by 3
Addressing Crises in Teenage Pregnancy
Doghor, O. N., Nomamiukor, F. O., Okotcha, E. N., & Onigu-Otite, E. (2019) · Adolescent Psychiatry · doi:10.2174/2210676609666190531102808 · Cited by 3
Exposure to Teratogens as a Risk Factor for Psychopathology
Doyle, L. R., Crocker, N., Fryer, S. L., & Mattson, S. N. (2017) · Wiley eBooks · doi:10.1002/9781394258932.ch9 · Cited by 3
The Role of Serotonin in Brain Development: From Molecular Pathways to Neurodevelopmental Risk
Chan, W. K., Rasmusson, S., Shiadeh, S. M. J., Wilhelmsson, R., Johansson, M. E., Elfving, B., Müller, H. K., Mallard, C. E., & Ardalan, M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01746-2 · Cited by 2
Bondi, D. S., Khan, O., & Hageman, J. R. (2016) · NeoReviews · doi:10.1542/neo.17-7-e356 · Cited by 2
Surgical radiofrequency ablation for atrial fibrillation: the Christchurch, New Zealand experience.
Coolbear, F., & Crozier, I. (2011) · PubMed · Cited by 2
Neurological evaluation and management of autism spectrum disorder
Goodspeed, K., Haffner, D. N., Golla, S., Morris, M. A., & Evans, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00023-4 · Cited by 2
Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay
(2014) · PEDIATRICS · doi:10.1542/peds.2013-3406d · Cited by 2
From parents to offspring: a comprehensive review of antidepressant-linked reproductive risks
Wu, S., Yan, F., Wei, Y., Liu, Q., Yue, Q., Huang, G., Li, X., Ji, Z., Ni, J., & Xu, W. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf156 · Cited by 1
van der Veere, C. N., den Heijer, A. E., & Bos, A. F. (2025) · Early Human Development · doi:10.1016/j.earlhumdev.2025.106405 · Cited by 2
Praxis der Pharmakotherapie der Depression in Schwangerschaft und Stillzeit
Bergemann, N. (2016) · Springer eBooks · doi:10.1007/978-3-662-50347-8_15 · Cited by 1
Is meconium exposure associated with autism spectrum disorders in children?
Jenabi, E., Ayubi, E., Khazaei, S., Bashirian, S., & Khazaei, M. (2020) · Korean Journal of Pediatrics · doi:10.3345/cep.2020.01053 · Cited by 1
Perinatal complications, environmental factors and autism spectrum disorders
Mandić-Maravić, V., Pejovic-Milovancevic, M. M., Pekmezovic, T. D., Pljesa-Ercegovac, M. S., Mitković-Vončina, M., & Lečić‐Toševski, D. (2016) · Medicinski podmladak · doi:10.5937/mp67-12844 · Cited by 1
Krajewska, K., & Słowińska, A. (2017) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2017.0006 · Cited by 1
Grigoriadis, S., & Peer, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-92919-4_5 · Cited by 1
Risk Factors of Autism Spectrum Disorders. Literature Review
Боднарь, Л. А., Скрипников, А. Н., Zhyvotovska, L. V., Фисун, Ю. А., & Bodnar, V. A. (2021) · Психиатрия психотерапия и клиническая психология · doi:10.34883/pi.2021.12.2.010 · Cited by 1
Autism Spectrum Disorder Severity, Developmental Delays, and Overweight/Obese Weight Status
Dempsey, J. R., & Dempsey, A. G. (2018) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.10.046 · Cited by 1
Perturbações do Espetro do Autismo: Fatores de Risco e Protetores
Santos, M. A. S. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/1875-9d80
Prenatal Antidepressant Use and Risk of Autism Spectrum Disorders in Children
Link, N. A., & Temple, M. E. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2016.0736
Psychotropic Medication in Pregnancy: Focus on Child Outcomes
Power, J., Galbally, M., & Lewis, A. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-32358-9_6
Making Sense Out of the Controversy: Use of SSRIs in Pregnancy
Ortega, M. V., & Urato, A. C. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0173-z
Cellular and Molecular Analysis of Axon Development in Zebrafish
Xing, L. (2016) · J. Willard Marriott Library · doi:10.26053/0h-q2x3-eq00
Girardi, A. M. (2017) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/7827
Doyle, L. R., & Mattson, S. N. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190634841.013.39
Pearlstein, T. B., Flynn, E., & Monzon, C. (2014) · Springer eBooks · doi:10.1007/978-1-4614-1244-1_3
Psychopharmakotherapie und psychiatrische Begleitung in Schwangerschaft und Stillzeit
Schaefer, C., Dorsch, V., & Rohde, A. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_90-1
Psychopharmakotherapie und psychiatrische Begleitung in Schwangerschaft und Stillzeit
Schaefer, C., Dorsch, V., & Rohde, A. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_90
Simoni, M. K., & Yonkers, K. A. (2018) · Wiley eBooks · doi:10.1002/9781119072980.ch36
Avaliação da infecção do vírus Influenza em astrócitos
de Freitas, A. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.10.2021.tde-06052022-120541
Oakly, A. (2015) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17013845
Skjeldal, O. H., & Isaksen, J. (2023) · Translational Science of Rare Diseases · doi:10.3233/trd-230058 · Cited by 3
Fujii, K., Tsuji, S., Ono, M., Yamazaki, H., Murakami, T., & Ozeki, Y. (2024) · Women s Health Reports · doi:10.1089/whr.2023.0112
Neonatal therapy after maternal central neurotropic drug exposure—a retrospective cohort study
Wecker, S. N., Dammert, A. S., Scholz, C., Krüger, M., Hauer, J., & Brickmann, C. (2024) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2024.2356038
Chapter 12. Pharmacotherapy of Specific Populations
(2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551289.cd12
Neurological evaluation and management of autism spectrum disorder
Goodspeed, K., Haffner, D. N., Golla, S., Morris, M. A., & Evans, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00042-x
Craig, A. M., Clemens, K. J., & Leigh, S. (2026) · Clinical Science · doi:10.1042/cs20250049
Metadata
- Authors
- Harrington, R. A., Lee, L.-C., Crum, R. M., Zimmerman, A. W., & Hertz-Picciotto, I.
- Affiliations
- Johns Hopkins University (US)
- University of Massachusetts Chan Medical School (US)
- Department of Public Health Sciences and the MIND Institute, University of California, Davis, Davis, California
- ORCID
- Zimmerman, Andrew W.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2014-05-01
- Volume
- 133
- Issue
- 5
- Pages
- e1241-e1248
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC4006441
- OpenAlex
- W2105930613
- Cited by
- 174
- References
- 50
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 13 · 2020: 17 · 2019: 15 · 2018: 21 · 2017: 25 · 2016: 34 · 2015: 16 · 2014: 7
- FWCI
- 26.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- PEDIATRICS (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Autism Speaks
- National Institutes of Health (ES11269)
- National Institute of Environmental Health Sciences (R01ES015359, P01ES011269)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- prenatal SSRI exposure, selective serotonin reuptake inhibitors, autism spectrum disorder, developmental delay, maternal mental health, maternal depression, first trimester exposure, third trimester exposure, sex differences, CHARGE study, maternal medication use
- MeSH terms
- California, Developmental Disabilities, Child Development Disorders, Pervasive, Child, Preschool, Drug Utilization, Female, Humans, Male, Pregnancy, Pregnancy Trimester, First, Pregnancy Trimester, Third, Prenatal Exposure Delayed Effects, Sex Factors, Odds Ratio, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
